Blood and blood treatments

During 2020, COVID-19 or CoV2-SARS dominated the public and medical community's discourse, thus prompting a preponderance of COVID-driven research. Despite many resulting studies, few new insights emerged regarding blood components treatments, focus this chapter. The pandemic led to resurgence interest in convalescent plasma and, by extension, freeze-dried as treatment options for Coronavirus. Several such studies are summarized. Other research topics include coagulation, treatments iron deficiency anemia, newly diagnosed multiple myeloma. While volume is devoted exploring reporting pharmacological side effects, most detailed significant adverse events.